These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8793842)

  • 21. Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin.
    Stapleton JT; Jansen R; Lemon SM
    Gastroenterology; 1985 Sep; 89(3):637-42. PubMed ID: 2991071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A-virus in cell culture. V. Neutralizing antibodies against hepatitis A-virus.
    Zahn J; Vallbracht A; Flehmig B
    Med Microbiol Immunol; 1984; 173(1):9-17. PubMed ID: 6088963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and adaptation characteristics of hepatitis A virus in primary African green monkey kidney cells: production of antigen useful for ELISA serology.
    Wang KQ; Nielsen CM; Vestergaard BF
    Intervirology; 1985; 24(2):99-107. PubMed ID: 2997078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum neutralizing antibody response to hepatitis A virus.
    Lemon SM; Binn LN
    J Infect Dis; 1983 Dec; 148(6):1033-9. PubMed ID: 6317766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infrared fluorescent immunofocus assay (IR-FIFA) for the quantitation of non-cytopathic and minimally cytopathic viruses.
    Counihan NA; Daniel LM; Chojnacki J; Anderson DA
    J Virol Methods; 2006 Apr; 133(1):62-9. PubMed ID: 16300833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus.
    Nasser AM; Metcalf TG
    Appl Environ Microbiol; 1987 Dec; 53(12):2967-71. PubMed ID: 2829721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of anti-hepatitis A virus neutralizing antibodies in a microplate enzyme immunoassay.
    Azizi A; Sirskyj D; Weltzin R; Anderson DE; Diaz-Mitoma F
    J Med Microbiol; 2009 Nov; 58(Pt 11):1433-1436. PubMed ID: 19608692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive immunization against hepatitis A.
    Stapleton JT
    Vaccine; 1992; 10 Suppl 1():S45-7. PubMed ID: 1335658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A.
    Delem A; Safary A; De Namur F; Hauser P; D'Hondt E
    Vaccine; 1993; 11(4):479-84. PubMed ID: 8385844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin.
    Lemon SM; Murphy PC; Provost PJ; Chalikonda I; Davide JP; Schofield TL; Nalin DR; Lewis JA
    J Infect Dis; 1997 Jul; 176(1):9-19. PubMed ID: 9207344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used.
    Berger R; Just M; Althaus B
    J Virol Methods; 1993 Aug; 43(3):287-97. PubMed ID: 8408443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propagation of hepatitis A virus in human diploid fibroblast cells.
    Wang ZQ; Ma L; Gao H; Dong XG
    Acta Virol; 1986 Nov; 30(6):463-7. PubMed ID: 2881465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203).
    Villar LM; Amado LA; Gaspar AM
    Braz J Med Biol Res; 2004 Jul; 37(7):1023-7. PubMed ID: 15264009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of IgM against hepatitis A virus using tissue culture derived antigen.
    Chitambar SD; Arankalle VA; Banerjee K
    Indian J Med Res; 1991 Jan; 93():19-21. PubMed ID: 1850714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.